Renaissance Technologies’s Enfusion, Inc. ENFN Stock Holding History

Renaissance Technologies’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-334,978	Closed	-$3.74M	–	3995
2025 Q1	$3.74M	Buy	334,978 +166,581	+99%	+$1.84M	0.01%	1599
2024 Q4	$1.73M	Buy	168,397 +28,897	+21%	+$279K	﹤0.01%	2146
2024 Q3	$1.32M	Buy	139,500 +42,400	+44%	+$366K	﹤0.01%	2281
2024 Q2	$827K	Buy	97,100 +60,811	+168%	+$556K	﹤0.01%	2427
2024 Q1	$336K	Buy	36,289 +20,289	+127%	+$179K	﹤0.01%	3043
2023 Q4	$155K	Buy	+16,000	New	+$149K	﹤0.01%	3205
2023 Q3	–	Sell	-30,000	Closed	-$337K	–	4201
2023 Q2	$337K	Sell	30,000 -40,800	-58%	-$362K	﹤0.01%	3079
2023 Q1	$743K	Buy	+70,800	New	+$780K	﹤0.01%	2660
2022 Q1	–	Sell	-16,300	Closed	-$341K	–	4553
2021 Q4	$341K	Buy	+16,300	New	+$329K	﹤0.01%	3280

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Renaissance Technologies's ENFN Position: Q2 2025 in Review

Renaissance Technologies sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 334,978 shares — an estimated $3.74M sold.

Renaissance Technologies first reported a position in ENFN in Q4 2021 and held it in 9 quarters. The position peaked at $3.74M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Renaissance Technologies reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Renaissance Technologies sold 334,978 Enfusion, Inc. shares in Q2 2025, an estimated $3.74M.
Renaissance Technologies first reported a position in Enfusion, Inc. in Q4 2021 and held it in 9 quarters.
Renaissance Technologies's Enfusion, Inc. position peaked at $3.74M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.